Article: Manhattan Scientifics Signs LOI to Acquire Rights to Early Cancer Detection System Developed by Dr. Edward R. Flynn.

Manhattan Scientifics (OTCBB: MHTX) announced that it has entered into a non-binding letter of intent (LOI) with Edward R. Flynn, Ph.D. and his company, Senior Scientific, LLC, to acquire all the manufacturing and marketing rights, together with all commercial rights associated with Dr. Flynn's patents and IP in the emerging field of nanomedicine. Dr. Flynn's work is focused on the biomagnetic detection of cancer and other diseases through magnetic field sensors with enhanced accuracy.

The details of the planned acquisition were not disclosed. A definitive agreement is expected to be concluded within 60 days.

Manhattan's CEO Manny Tsoupanarias stated, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!